AxoGen Gross Margin 2010-2025 | AXGN
Current and historical gross margin for AxoGen (AXGN) over the last 10 years. The current gross profit margin for AxoGen as of March 31, 2025 is %.
| AxoGen Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.20B | $0.14B | 73.85% |
| 2024-12-31 | $0.19B | $0.14B | 75.94% |
| 2024-09-30 | $0.18B | $0.14B | 75.14% |
| 2024-06-30 | $0.17B | $0.13B | 76.30% |
| 2024-03-31 | $0.16B | $0.13B | 77.91% |
| 2023-12-31 | $0.16B | $0.12B | 76.73% |
| 2023-09-30 | $0.15B | $0.11B | 75.00% |
| 2023-06-30 | $0.15B | $0.11B | 76.35% |
| 2023-03-31 | $0.14B | $0.11B | 77.08% |
| 2022-12-31 | $0.14B | $0.11B | 78.26% |
| 2022-09-30 | $0.13B | $0.11B | 82.09% |
| 2022-06-30 | $0.13B | $0.11B | 82.03% |
| 2022-03-31 | $0.13B | $0.10B | 80.47% |
| 2021-12-31 | $0.13B | $0.10B | 81.25% |
| 2021-09-30 | $0.13B | $0.11B | 82.03% |
| 2021-06-30 | $0.13B | $0.11B | 82.31% |
| 2021-03-31 | $0.12B | $0.10B | 83.05% |
| 2020-12-31 | $0.11B | $0.09B | 81.98% |
| 2020-09-30 | $0.11B | $0.09B | 81.31% |
| 2020-06-30 | $0.10B | $0.08B | 80.58% |
| 2020-03-31 | $0.11B | $0.09B | 81.48% |
| 2019-12-31 | $0.11B | $0.09B | 83.18% |
| 2019-09-30 | $0.10B | $0.09B | 84.31% |
| 2019-06-30 | $0.10B | $0.08B | 84.38% |
| 2019-03-31 | $0.09B | $0.08B | 84.44% |
| 2018-12-31 | $0.08B | $0.07B | 84.52% |
| 2018-09-30 | $0.08B | $0.07B | 83.33% |
| 2018-06-30 | $0.07B | $0.06B | 84.51% |
| 2018-03-31 | $0.07B | $0.06B | 86.15% |
| 2017-12-31 | $0.06B | $0.05B | 85.00% |
| 2017-09-30 | $0.05B | $0.05B | 87.04% |
| 2017-06-30 | $0.05B | $0.04B | 87.76% |
| 2017-03-31 | $0.04B | $0.04B | 88.64% |
| 2016-12-31 | $0.04B | $0.04B | 90.00% |
| 2016-09-30 | $0.04B | $0.03B | 86.49% |
| 2016-06-30 | $0.03B | $0.03B | 85.29% |
| 2016-03-31 | $0.03B | $0.03B | 83.33% |
| 2015-12-31 | $0.03B | $0.02B | 81.48% |
| 2015-09-30 | $0.02B | $0.02B | 83.33% |
| 2015-06-30 | $0.02B | $0.02B | 80.95% |
| 2015-03-31 | $0.02B | $0.02B | 78.95% |
| 2014-12-31 | $0.02B | $0.01B | 76.47% |
| 2014-09-30 | $0.02B | $0.01B | 73.33% |
| 2014-06-30 | $0.01B | $0.01B | 69.23% |
| 2014-03-31 | $0.01B | $0.01B | 66.67% |
| 2013-12-31 | $0.01B | $0.01B | 72.73% |
| 2013-09-30 | $0.01B | $0.01B | 80.00% |
| 2013-06-30 | $0.01B | $0.01B | 77.78% |
| 2013-03-31 | $0.01B | $0.01B | 87.50% |
| 2012-12-31 | $0.01B | $0.01B | 75.00% |
| 2012-09-30 | $0.01B | $0.01B | 71.43% |
| 2012-06-30 | $0.01B | $0.00B | 66.67% |
| 2012-03-31 | $0.01B | $0.00B | 60.00% |
| 2011-12-31 | $0.00B | $0.00B | 75.00% |
| 2011-09-30 | $0.01B | $0.00B | 60.00% |
| 2011-06-30 | $0.01B | $0.00B | 80.00% |
| 2011-03-31 | $0.00B | $0.00B | 75.00% |
| 2010-12-31 | $0.00B | $0.00B | 66.67% |
| 2010-09-30 | $0.03B | $0.03B | 100.00% |
| 2010-06-30 | $0.02B | $0.02B | 100.00% |
| 2010-03-31 | $0.03B | $0.03B | 100.00% |
| 2009-12-31 | $0.03B | $0.03B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.500B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $198.309B | 86.86 |
| Thermo Fisher Scientific (TMO) | United States | $149.665B | 18.10 |
| Edwards Lifesciences (EW) | United States | $45.813B | 30.04 |
| Alcon (ALC) | Switzerland | $42.010B | 28.39 |
| IDEXX Laboratories (IDXX) | United States | $41.401B | 47.58 |
| DexCom (DXCM) | United States | $33.529B | 51.82 |
| IQVIA Holdings (IQV) | United States | $24.064B | 13.48 |
| STERIS (STE) | Ireland | $23.814B | 26.23 |
| Mettler-Toledo (MTD) | United States | $23.716B | 28.20 |
| Waters (WAT) | United States | $20.452B | 28.86 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.615B | 0.00 |
| Hologic (HOLX) | United States | $13.819B | 15.02 |
| Sysmex ADR (SSMXY) | Japan | $10.581B | 30.02 |
| Penumbra (PEN) | United States | $9.920B | 77.86 |
| Masimo (MASI) | United States | $8.948B | 33.01 |
| Globus Medical (GMED) | United States | $7.982B | 19.02 |
| Glaukos (GKOS) | United States | $5.416B | 0.00 |
| Teleflex (TFX) | United States | $5.288B | 8.73 |
| TransMedics (TMDX) | United States | $4.192B | 91.13 |
| Integer Holdings (ITGR) | United States | $4.106B | 21.52 |
| PROCEPT BioRobotics (PRCT) | United States | $3.206B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.367B | 14.09 |
| Veracyte (VCYT) | United States | $2.094B | 29.39 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.19 |
| Elekta AB (EKTAY) | Sweden | $1.985B | 17.84 |
| Alphatec Holdings (ATEC) | United States | $1.798B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.226B | 114.84 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.957B | 5.09 |
| Beta Bionics (BBNX) | United States | $0.810B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.28 |
| RxSight (RXST) | United States | $0.631B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.568B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.534B | 12.53 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| NeuroPace (NPCE) | United States | $0.428B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| AngioDynamics (ANGO) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.296B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.93 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.201B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.169B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.46 |